This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institution
BMC Health Services Research Open Access 03 September 2021
-
Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
Clinical Rheumatology Open Access 03 July 2021
-
Revisiting the JOQUER trial: stratification of primary Sjögren’s syndrome and the clinical and interferon response to hydroxychloroquine
Rheumatology International Open Access 24 June 2021
Access options
Subscribe to Journal
Get full journal access for 1 year
$79.00
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Buy article
Get time limited or full article access on ReadCube.
$32.00
All prices are NET prices.
References
Suarez-Almazor ME et al. (2000) Antimalarials for treating rheumatoid arthritis. Cochrane Database Syst Rev, Issue 4, Art. No CD000959
O'Dell JR et al. (1996) Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 334: 1287–1291
Rynes RI (1997) Antimalarial drugs in the treatment of rheumatological diseases. Br J Rheumatol 36: 799–805
Weber SM and Levitz SM (2000) Chloroquine interferes with lipopolysaccharide-induced TNF-alpha gene expression by a nonlysosomotropic mechanism. J Immunol 165: 1534–1340
Weber SM et al. (2002) Inhibition of mitogen-activated protein kinase signaling by chloroquine. J Immunol 168: 5303–5309
Kim WU et al. (2006) Hydroxychloroquine potentiates Fas-mediated apoptosis of rheumatoid synoviocytes. Clin Exp Immunol 144: 503–511
Leadbetter EA et al. (2002) Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416: 603–607
Kyburz D and Gay S (2003) Toll-like receptors direct antimicrobial immune responses—and drive arthritis? Curr Rheumatol Rep 5: 407–408
van der Heijden IM et al. (2000) Presence of bacterial DNA and bacterial peptidoglycans in joints of patients with rheumatoid arthritis and other arthritides. Arthritis Rheum 43: 593–598
Brentano F et al. (2005) RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via Toll-like receptor 3. Arthritis Rheum 52: 2656–2665
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Kyburz, D., Brentano, F. & Gay, S. Mode of action of hydroxychloroquine in RA—evidence of an inhibitory effect on toll-like receptor signaling. Nat Rev Rheumatol 2, 458–459 (2006). https://doi.org/10.1038/ncprheum0292
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0292
This article is cited by
-
Antimalarial drugs—are they beneficial in rheumatic and viral diseases?—considerations in COVID-19 pandemic
Clinical Rheumatology (2022)
-
Inhibition of NETosis for treatment purposes: friend or foe?
Molecular and Cellular Biochemistry (2022)
-
The effect of an electronic medical record intervention on hydroxychloroquine prescribing habits and surveyed providers’ opinions of the 2016 American Academy of Ophthalmology guidelines in the rheumatology and dermatology practices of an academic institution
BMC Health Services Research (2021)
-
The effect of hydroxychloroquine on platelet activation in model experiments
Journal of Thrombosis and Thrombolysis (2021)
-
Prospects for Therapies in Osteoarthritis
Calcified Tissue International (2021)